Richard L. Guerrant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Richard L. Guerrant has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Aldo Angelo Moreira Lima
Universidade Federal do Ceará, Brasil; Universidade Federal do Ceará, Brasil
2 shared publications - Sean R. Moore
Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
2 shared publications - Amidou Samie
Department of Biochemistry and Microbiology, Faculty of Science, Engineering and Agriculture, University of Venda, Thohoyandou 0950, South Africa
1 shared publication - Andi L. Shane
Division of Infectious Disease, Department of Pediatrics, Emory University School of Medicine, and Children’s Healthcare of Atlanta, Atlanta, GA
1 shared publication - Balakrishnan Siddartha Ramakrishna
Division of Medical Gastroenterology, Department of Gastroenterology, Hepatobiliary Science and Transplantation, SRM Institutes for Medical Science, Chennai, Tamil Nadu, India
1 shared publication Breyette Lorntz
Department of Medicine, Division of Geographic and International Medicine, University of Virginia (UVa) School of Medicine, Charlottesville, VA, USA
1 shared publication
Latest Publications
- 6 November 2019
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 101 (5) , 1027-1033
Prevalence of Virulence Genes in Enteroaggregative Escherichia coli Isolates from Young Children from Rural South Africa
In this study, we report on the prevalence of 19 virulence genes in enteroaggregative Escherichia coli (EAEC) isolates from northern South Africa. Stool samples obtained prospectively from 97 children from 1 to 12 months of age were analyzed, and EAEC isolates were confirmed based on the presence of aaiC or aatA genes. We investigated 177 enteroaggregative Escherichia coli isolates for the prevalence of virulence genes using multiplex polymerase chain reaction. The chromosomal gene aaiC was detected at higher frequency (48.0%) compared with aatA (26.0%). The gene encoding the open reading frame Orf61 was the most prevalent putative virulence trait detected among the isolates (150/177; 84.7%). None of the genes was statistically associated with diarrhea (P > 0.05). Detection rates were higher during 7–12 month of life with an association observed for the pic gene and the age group 7–12 months (P = 0.04). Winter was the season with the highest detection rates. Our data reveal a high prevalence of Orf61, Orf3, and astA in South African EAEC isolates. Specific genes may provide additional markers for the study of disease associations with age and season of sample collection.
- 6 November 2019
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 101 (5) , 1027-1033
Prevalence of Virulence Genes in Enteroaggregative Escherichia coli Isolates from Young Children from Rural South Africa
In this study, we report on the prevalence of 19 virulence genes in enteroaggregative Escherichia coli (EAEC) isolates from northern South Africa. Stool samples obtained prospectively from 97 children from 1 to 12 months of age were analyzed, and EAEC isolates were confirmed based on the presence of aaiC or aatA genes. We investigated 177 enteroaggregative Escherichia coli isolates for the prevalence of virulence genes using multiplex polymerase chain reaction. The chromosomal gene aaiC was detected at higher frequency (48.0%) compared with aatA (26.0%). The gene encoding the open reading frame Orf61 was the most prevalent putative virulence trait detected among the isolates (150/177; 84.7%). None of the genes was statistically associated with diarrhea (P > 0.05). Detection rates were higher during 7–12 month of life with an association observed for the pic gene and the age group 7–12 months (P = 0.04). Winter was the season with the highest detection rates. Our data reveal a high prevalence of Orf61, Orf3, and astA in South African EAEC isolates. Specific genes may provide additional markers for the study of disease associations with age and season of sample collection.
- 1 August 2017
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 64 (4) , 815-836
The Burden of Enteropathy and “Subclinical” Infections
- 1 August 2017
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 64 (4) , 815-836
The Burden of Enteropathy and “Subclinical” Infections
- Open Access
- 28 January 2016
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 2 (2) , 114-115
Decoding Hidden Messages: Can Fecal Host Transcriptomics Open Pathways to Understanding Environmental Enteropathy?
- 28 January 2016
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 2 (2) , 114-115
Open AccessDecoding Hidden Messages: Can Fecal Host Transcriptomics Open Pathways to Understanding Environmental Enteropathy?
- Open Access
- 18 January 2013
- Published by Springer Nature in BMC Medical Education
- Vol. 13 (1) , 3
Global health education in U.S. Medical schools
Interest in global health (GH) among medical students worldwide is measurably increasing. There is a concomitant emphasis on emphasizing globally-relevant health professions education. Through a structured literature review, expert consensus recommendations, and contact with relevant professional organizations, we review the existing state of GH education in US medical schools for which data were available. Several recommendations from professional societies have been developed, along with a renewed emphasis on competencies in global health. The implementation of these recommendations was not observed as being uniform across medical schools, with variation noted in the presence of global health curricula. Recommendations for including GH in medical education are suggested, as well as ways to formalize GH curricula, while providing flexibility for innovation and adaptation
- 18 January 2013
- Published by Springer Nature in BMC Medical Education
- Vol. 13 (1) , 3
Open AccessGlobal health education in U.S. Medical schools
Interest in global health (GH) among medical students worldwide is measurably increasing. There is a concomitant emphasis on emphasizing globally-relevant health professions education. Through a structured literature review, expert consensus recommendations, and contact with relevant professional organizations, we review the existing state of GH education in US medical schools for which data were available. Several recommendations from professional societies have been developed, along with a renewed emphasis on competencies in global health. The implementation of these recommendations was not observed as being uniform across medical schools, with variation noted in the presence of global health curricula. Recommendations for including GH in medical education are suggested, as well as ways to formalize GH curricula, while providing flexibility for innovation and adaptation
- Open Access
- 1 August 2011
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 31 (3) , 201-203
Enteric protozoa and human potential
(2011). Enteric protozoa and human potential. Annals of Tropical Paediatrics: Vol. 31, No. 3, pp. 201-203.
- 1 August 2011
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 31 (3) , 201-203
Open AccessEnteric protozoa and human potential
(2011). Enteric protozoa and human potential. Annals of Tropical Paediatrics: Vol. 31, No. 3, pp. 201-203.
- 28 May 2011
- Published by Taylor & Francis in Gut Microbes
- Vol. 2 (3) , 198-207
Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report
Infectious disease in the developing world continues to represent one of the greatest challenges facing humanity. Every year over a million children suffer and die from the sequela of enteric infections, while in 2008 it is estimated almost 2.7 million (UNAIDS 2009 update) adults and children became infected with human immunodeficiency virus (HIV). While oral rehydration therapy for diarrhea, and antiretrovirals (ARV) for HIV are critical, there is a place for adjunctive therapies to improve quality of life. The importance of the human microbiota in retaining health is now recognized, as is the concept of replenishing beneficial microbes through probiotic treatments. Studies have shown that probiotics can reduce the duration of diarrhea, improve gut barrier function, help prevent bacterial vaginosis (BV), and enhance immunity even in HIV-infected subjects. However, many issues remain before the extent of probiotic benefits can be verified, and their application to the developing world realised. This consensus report outlines the potential probiotic, and to a lesser extent prebiotic, applications in resource disadvantages settings, and recommends steps that could bring tangible relief to millions of people. The challenges to both efficacy and effectiveness studies in these settings include a lack of infrastructure and funding for scientists, students and research projects in developing countries; making available clinically proven probiotic and prebiotic products at affordable prices; and undertaking appropriately designed clinical trials. We present a roadmap on how efficacy studies may be conducted in a resource disadvantages setting among persons with chronic diarrhea and HIV. These examples and the translation of efficacy into effectiveness are described.
- 28 May 2011
- Published by Taylor & Francis in Gut Microbes
- Vol. 2 (3) , 198-207
Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report
Infectious disease in the developing world continues to represent one of the greatest challenges facing humanity. Every year over a million children suffer and die from the sequela of enteric infections, while in 2008 it is estimated almost 2.7 million (UNAIDS 2009 update) adults and children became infected with human immunodeficiency virus (HIV). While oral rehydration therapy for diarrhea, and antiretrovirals (ARV) for HIV are critical, there is a place for adjunctive therapies to improve quality of life. The importance of the human microbiota in retaining health is now recognized, as is the concept of replenishing beneficial microbes through probiotic treatments. Studies have shown that probiotics can reduce the duration of diarrhea, improve gut barrier function, help prevent bacterial vaginosis (BV), and enhance immunity even in HIV-infected subjects. However, many issues remain before the extent of probiotic benefits can be verified, and their application to the developing world realised. This consensus report outlines the potential probiotic, and to a lesser extent prebiotic, applications in resource disadvantages settings, and recommends steps that could bring tangible relief to millions of people. The challenges to both efficacy and effectiveness studies in these settings include a lack of infrastructure and funding for scientists, students and research projects in developing countries; making available clinically proven probiotic and prebiotic products at affordable prices; and undertaking appropriately designed clinical trials. We present a roadmap on how efficacy studies may be conducted in a resource disadvantages setting among persons with chronic diarrhea and HIV. These examples and the translation of efficacy into effectiveness are described.
- 1 July 2002
- Published by Elsevier in Archives of Medical Research
- Vol. 33 (4) , 351-355
Magnitude and Impact of Diarrheal Diseases
- 1 July 2002
- Published by Elsevier in Archives of Medical Research
- Vol. 33 (4) , 351-355
Magnitude and Impact of Diarrheal Diseases